中建富通(00138.HK)終止兒童產品貿易業務及原部件製造業務
中建富通(00138.HK)公布,指工業產品業務已經受到激烈競爭、中美之間貿易磨擦升溫、全球經濟倒退及新型冠狀病毒爆發等多種不利因素的綜合影響;另外,公司於今日(24日)接獲大灣區投資通知,大灣區投資集團不再需要集團供應原部件產品。由於經營環境惡化,工業產品業務的銷售額在今年上半年持續大幅下跌。工業產品業務在過往數月沒有接到新的訂單,而手頭上亦沒有未完成的訂單。
公司指,未能預知全球消費市場何時得以復蘇,決定在今日終止工業產品業務。由於工業產品業務處於虧損狀態,預期終止工業產品業務不會對集團的經營業績或財務狀況造成任何重大不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.